2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Evkeeza Market?
The increasing prevalence of genetic disorders is expected to propel the growth of the Evkeeza market. Genetic disorders, caused by abnormalities in DNA, are on the rise due to improved diagnostics and environmental factors. Evkeeza is used to treat homozygous familial hypercholesterolemia (HoFH), a genetic disorder that inhibits ANGPTL3 to reduce LDL cholesterol in affected individuals. For instance, in June 2024, the American Society of Hematology projected a 30% increase in the global population with sickle cell disease (SCD) by 2050. Therefore, the rising prevalence of genetic disorders is driving the growth of the Evkeeza market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20070&type=smp
How Will the Growth Rate of theEvkeeza Market Impact Industry Trends by 2034?
The evkeeza market has grown at XX (HCAGR). It is forecast to rise from $XX million in 2024 to $XX million in 2025 at a CAGR of XX%. Drivers included supportive policies, advances in genomics, aging population, favorable regulations, and congenital condition management.
The evkeeza market size is expected to grow at XX (FCAGR) in the next few years, reaching $XX million by 2029, with a CAGR of XX%. The market growth is attributed to the rising prevalence of hypercholesterolemia, rare disease burden, growing neurological disease cases, and increasing healthcare expenditure. Trends include specialized medication development, personalized medicine, telemedicine, patient support programs expansion, and regulatory approvals.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20070
What Are the Key Market Innovations in theEvkeeza Market Over the Coming Years?
In the Evkeeza market, a notable trend is gaining regulatory clearance to broaden treatment for patients with homozygous familial hypercholesterolemia (HoFH). In March 2023, Regeneron Pharmaceuticals Inc. received FDA approval for Evkeeza (evinacumab-dgnb) for children aged 5 to 11 years with HoFH. This marks the first ANGPTL3 inhibitor approved for this age group, with clinical trials showing a 48% reduction in LDL-C levels over 24 weeks when used alongside other therapies.
Who Are the Top Companies Driving Innovation and Growth in theEvkeeza Market?
Major companies operating in the evkeeza market include Regeneron Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/evkeeza-global-market-report
Which Key Market Segments Comprise the Evkeeza Market and Drive Its Revenue Growth?
The evkeeza market covered in this report is segmented –
1) By Indication: Primary Hypercholesterolemia, Homozygous Familial Hypercholesterolemia
2) By Route Of Administration: Intravenous (IV) Infusion, Self-Administration, Subcutaneous (SC) Administration, Hospital Infusion Centers, Infusion In Ambulatory Care Settings
3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20070&type=smp
Which Regions Are Emerging as Leaders in the Evkeeza Market?
North America was the largest region in the evkeeza market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the evkeeza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Evkeeza Market 2025, By The Business Research Company:
Cholesterol Test Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report
Antibody Contract Manufacturing Global Market Report 2025
Next-Generation Antibody Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: